Linscomb & Williams, Inc. Eli Lilly & CO Transaction History

Linscomb & Williams, Inc.

$1.93 Billion
Q2 2024

A detailed history of Linscomb & Williams, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Linscomb & Williams, Inc. holds 3,273 shares of LLY stock, worth $2.98 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

3,273

Previous 3,389 3.42%

Holding current value

$2.98 Million

Previous $2.64 Million 12.41%

% of portfolio

0.15%

Previous 0.14%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$724.87 - $909.04 $84,084 - $105,448	-116 Reduced 3.42%	3,273 $2.96 Million
Q1 2024 May 14, 2024	BUY	$592.2 - $792.28 $10,067 - $13,468	17 Added 0.5%	3,389 $2.64 Million
Q4 2023 Feb 06, 2024	SELL	$525.19 - $619.13 $125,520 - $147,972	-239 Reduced 6.62%	3,372 $1.97 Million
Q3 2023 Oct 10, 2023	SELL	$434.7 - $599.3 $16,518 - $22,773	-38 Reduced 1.04%	3,611 $1.94 Million
Q2 2023 Aug 09, 2023	SELL	$350.74 - $468.98 $2,805 - $3,751	-8 Reduced 0.22%	3,649 $1.71 Million
Q1 2023 May 11, 2023	BUY	$310.63 - $364.82 $99,712 - $117,107	321 Added 9.62%	3,657 $1.26 Million
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $167,849 - $195,577	522 Added 18.55%	3,336 $1.22 Million
Q2 2022 Aug 15, 2022	SELL	$278.73 - $327.27 $56,303 - $66,108	-202 Reduced 6.7%	2,814 $912,000
Q1 2022 May 17, 2022	BUY	$234.69 - $291.66 $130,722 - $162,454	557 Added 22.65%	3,016 $864,000
Q4 2021 Feb 10, 2022	BUY	$224.85 - $279.04 $14,165 - $17,579	63 Added 2.63%	2,459 $679,000
Q3 2021 Nov 03, 2021	SELL	$221.6 - $272.71 $6,648 - $8,181	-30 Reduced 1.24%	2,396 $554,000
Q2 2021 Aug 10, 2021	BUY	$180.55 - $233.54 $5,235 - $6,772	29 Added 1.21%	2,426 $557,000
Q1 2021 May 12, 2021	SELL	$164.32 - $212.72 $2,136 - $2,765	-13 Reduced 0.54%	2,397 $448,000
Q4 2020 Feb 11, 2021	SELL	$130.46 - $172.63 $47,878 - $63,355	-367 Reduced 13.22%	2,410 $407,000
Q3 2020 Nov 13, 2020	BUY	$146.22 - $169.13 $21,201 - $24,523	145 Added 5.51%	2,777 $411,000
Q2 2020 Aug 11, 2020	SELL	$136.42 - $164.18 $10,367 - $12,477	-76 Reduced 2.81%	2,632 $432,000
Q4 2019 Feb 13, 2020	SELL	$106.92 - $132.43 $5,452 - $6,753	-51 Reduced 1.85%	2,708 $356,000
Q3 2019 Nov 08, 2019	SELL	$106.79 - $116.16 $1,281 - $1,393	-12 Reduced 0.43%	2,759 $309,000
Q2 2019 Aug 06, 2019	SELL	$110.79 - $129.32 $40,992 - $47,848	-370 Reduced 11.78%	2,771 $307,000
Q4 2018 Feb 08, 2019	BUY	$105.9 - $118.64 $10,166 - $11,389	96 Added 3.15%	3,141 $363,000
Q3 2018 Nov 08, 2018	SELL	$85.86 - $107.31 $37,778 - $47,216	-440 Reduced 12.63%	3,045 $327,000
Q2 2018 Aug 07, 2018	BUY	$75.7 - $86.88 $3,633 - $4,170	48 Added 1.4%	3,485 $297,000
Q1 2018 May 04, 2018	BUY	$74.21 - $87.6 $7,420 - $8,760	100 Added 3.0%	3,437 $266,000
Q4 2017 Feb 02, 2018	BUY	$81.94 - $87.89 $273,433 - $293,288	3,337	3,337 $282,000

Others Institutions Holding LLY

# of Institutions

3,887

Shares Held

763M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $864B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Linscomb & Williams, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Linscomb & Williams, Inc. with notifications on news.

Account

Linscomb & Williams, Inc. Eli Lilly & CO Transaction History